← Leaderboards
Robert Kalayjian
Case Western Reserve University
$38,398
Attributed
$38,398
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$38,398 · 2
By mechanism
M01$38,398 · 2
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Christopher C. Whalen$31,694,779
- Anna M Mandalakas$15,080,129
- Anita C Gilliam$2,181,316
- Jonathan S. Stamler$32,849,627
- Peter Scott Heeger$92,873,534
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationHiv InfectionsClinical ResearchHuman SubjectComorbidityCytomegalovirusDrug Screening /EvaluationEthambutolGraft Versus Host DiseaseHuman Immunodeficiency Virus 1IsoniazidLeukocyte Activation /TransformationLeukocyte TransfusionPharmacokineticsPyrazinamideTuberculosisAids TherapyVirus Infection MechanismAntitubercular AgentsBlood DonorBlood Transfusion
Grant awards (6)
VIRAL ACTIVATION TRANSFUSION STUDY (VATS)$0
M01 · FY2002 · RR
ANTITUBERCULOSIS AGENTS IN HIV INFECTED PERSONS W/ TB$0
M01 · FY2002 · RR
VIRAL ACTIVATION TRANSFUSION STUDY (VATS)$0
M01 · FY2001 · RR
ANTITUBERCULOSIS AGENTS IN HIV INFECTED PERSONS W/ TB$0
M01 · FY2001 · RR
VIRAL ACTIVATION TRANSFUSION STUDY (VATS)$19,199
M01 · FY2000 · RR
ANTITUBERCULOSIS AGENTS IN HIV INFECTED PERSONS W/ TB$19,199
M01 · FY2000 · RR